Invention Grant
- Patent Title: Crystalline forms of a triazolopyrimidine compound
-
Application No.: US16311638Application Date: 2017-06-19
-
Publication No.: US11091489B2Publication Date: 2021-08-17
- Inventor: Ying Huang , Bo Liu , Liang Mao , Long Wang , Liladhar Murlidhar Waykole , Lijun Zhang
- Applicant: NOVARTIS AG
- Applicant Address: CH Basel
- Assignee: NOVARTIS AG
- Current Assignee: NOVARTIS AG
- Current Assignee Address: CH Basel
- Agent Daniel E. Raymond
- Priority: WOPCT/CN2016/086350 20160620
- International Application: PCT/CN2017/089003 WO 20170619
- International Announcement: WO2017/219948 WO 20171228
- Main IPC: C07D487/04
- IPC: C07D487/04 ; A61P35/00 ; A61P35/02 ; A61K31/519
Abstract:
Provided herein are crystalline forms of a triazolopyrimidine compound, which is useful for treating a PRC2-mediated disease or disorder.
Public/Granted literature
- US20190211022A1 CRYSTALLINE FORMS OF A TRIAZOLOPYRIMIDINE COMPOUND Public/Granted day:2019-07-11
Information query
